Quarta, Leonardo
Mazzone, Elio
Cannoletta, Donato
Stabile, Armando
Scuderi, Simone
Barletta, Francesco
Cucchiara, Vito
Nocera, Luigi
Pellegrino, Antony
Robesti, Daniele
Leni, Riccardo
Zaurito, Paolo
Brembilla, Giorgio
De Cobelli, Francesco
Samanes Gajate, Ana Maria
Picchio, Maria
Chiti, Arturo
Montorsi, Francesco
Briganti, Alberto
Gandaglia, Giorgio
Funding for this research was provided by:
Italian Ministry of Health (Project GR-2018-12368369)
Article History
Received: 10 April 2024
Accepted: 4 June 2024
First Online: 11 June 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of IRCCS San Raffaele Hospital, Milan, Italy.Name of registry: clinicaltrials.govTrial registration number: NCT04832958Date of registration: 2021–04
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the images in Figures 1, 2 and 3.
: Financial interests: Alberto Briganti and Arturo Chiti declared their conflict of interest.Alberto Briganti declared the following conflict of interest:• Astellas Pharma Janseen-Cilag• OPKO Health• MDx Health• Bayer• miR Scientific• LLC (“miR”)• A3P biomedical• MSD/Astrazeneca• Ferring• Pfizer• Sandoz-Novartis• Telix Pharmaceuticals• European Urology, Editor in ChiefArturo Chiti declared the following conflict of interest:• Novartis, advisory board; speaker honorarium• AAA, advisory board; speaker honorarium• Sirtex, speaker honorarium• General Electric Healthcare, speaker’s honorarium• Telix, advisory board• Bracco, speaker honorarium• European Journal of Nuclear Medicine and Molecular Imaging, Editor in Chief